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Abstract
Background: Animal African trypanosomosis, a disease mainly caused by the protozoan parasite Trypanosoma congolense,i s
a major constraint to livestock productivity and has a significant impact in the developing countries of Africa. RNA
interference (RNAi) has been used to study gene function and identify drug and vaccine targets in a variety of organisms
including trypanosomes. However, trypanosome RNAi studies have mainly been conducted in T. brucei, as a model for
human infection, largely ignoring livestock parasites of economical importance such as T. congolense, which displays
different pathogenesis profiles. The whole T. congolense life cycle can be completed in vitro, but this attractive model
displayed important limitations: (i) genetic tools were currently limited to insect forms and production of modified
infectious BSF through differentiation was never achieved, (ii) in vitro differentiation techniques lasted several months, (iii)
absence of long-term bloodstream forms (BSF) in vitro culture prevented genomic analyses.
Methodology/Principal Findings: We optimized culture conditions for each developmental stage and secured the
differentiation steps. Specifically, we devised a medium adapted for the strenuous development of stable long-term BSF
culture. Using Amaxa nucleofection technology, we greatly improved the transfection rate of the insect form and designed
an inducible transgene expression system using the IL3000 reference strain. We tested it by expression of reporter genes
and through RNAi. Subsequently, we achieved the complete in vitro life cycle with dramatically shortened time
requirements for various wild type and transgenic strains. Finally, we established the use of modified strains for
experimental infections and underlined a host adaptation phase requirement.
Conclusions/Significance: We devised an improved T. congolense model, which offers the opportunity to perform
functional genomics analyses throughout the whole life cycle. It represents a very useful tool to understand pathogenesis
mechanisms and to study potential therapeutic targets either in vitro or in vivo using a mouse model.
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Introduction
Animal African Trypanosomosis (AAT) is a severe disease
caused by several species of African trypanosomes, flagellate
protozoan parasites transmitted by an insect fly vector. It affects
domestic livestock in sub-Saharan Africa and consequently has a
severe economic impact [1–3]. AAT is widely spread affecting 40
countries situated in regions that could potentially be the most
productive. The main pathological symptoms of animal trypano-
somosis are weight loss, anaemia, and immunosuppression, but the
mechanisms involved are poorly understood. It is estimated that
50 million cattle and 70 million small ruminants are at risk, costing
the continent between 1.5 and 5 billion US dollars per annum. In
terms of severity and consequences for productivity, T. congolense is
the main causative agent of AAT. This parasite has a complex life
cycle: bloodstream forms (BSF) proliferate in the blood of the
infected mammalian host and are ingested by tsetse during the
blood meal, procyclic forms (PCF) differentiate in the insect
midgut, migrate to the proboscis (mouth parts) where they attach
as epimastigote forms (EMF) and finally differentiate into infective
metacyclic forms (MCF) that are transmitted to a new mammalian
host during the next blood meal.
This parasite strongly hinders the agricultural development of
the sub-Saharan region and an understanding of the virulence
mechanisms is essential in order to block the parasite and/or the
associated pathogenesis. Such studies require functional charac-
terization of virulence genes based on genetic engineering. Genetic
tools are well established in the T. brucei parasite with wide use of
inducible transgene expression [4,5]. More specifically, gene
expression inactivation using RNA interference (RNAi) system
greatly contributed to the functional analysis of T. brucei genes to
such an extent that T. brucei has become the preferred model for
trypanosomiasis studies [6,7]. However, T. congolense is a strictly
intravascular parasite whereas T. brucei can leave blood vessels and
invade tissues implying differences in virulence mechanisms, host/
pathogens relationships and pathogenic effects between the two
species. Furthermore, while for T. brucei only the PCF and BSF
stages can be cultivated in vitro and differentiation is limited to one
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reproduced in vitro (cultivation of all the developmental stages
accomplishing all the differentiation steps) [8,9]. Especially, the in
vitro differentiation of the tsetse vector stages (from PCF to MCF)
was described much earlier, this process is termed metacyclogen-
esis [10]. Therefore, it will be very informative and useful to use T.
congolense not only as a model for AAT studies but also for
deciphering the mechanisms underlying the different differentia-
tion steps.
The major drawback we aim to overcome is that all cultivation
techniques currently available are limited even for the metacyclo-
genesis process (which could take several months [10]) resulting in
the quasi-absence of genetic tools. A single strain has been
developed for the inducible RNAi system in PCF (TRUM183
strain) [11], and only one recent study described genetic
modification of EMF (IL3000 strain) by transfection with a GFP
vector and subsequent differentiation into MCF [12]. However,
production of infectious BSF through differentiation of genetically
modified parasites has never been achieved. In addition, there is
an important heterogeneity between the T. congolense isolates used
despite the inclination to refer to the IL3000 clone since the
beginning of its genome sequencing project (Sanger Center, UK).
And, there are disparities regarding the in vitro differentiation
especially during metacyclogenesis and transfection efficiency [13]
(our data). Finally, the question of the infectivity/virulence of wild
type or genetically modified MCF differentiated in vitro has not
been addressed until now.
Another severe restriction in this research field is the lack of
stable long-term BSF culture. Some authors described BSF culture
systems [14,15] that turned out to be usable only for short-term
applications eliminating the possibility of performing drug trials
(requiring continuously dividing cultures) and above all, transfec-
tion assays, consequently resulting in the absence of functional
genomics for T. congolense BSF.
Because the T. congolense model displayed significant limitations,
we decided to undertake a systematic analysis of all the
developmental stages regarding culture methods, differentiation
efficiency, and transfection success rate by using 5 different wild
type isolates and 2 genetically modified cell-lines. In this work we
describe the success in developing an improved in vitro model and
standardized culture methods.
Materials and Methods
Cell cultures
Primary cultures of bovine aortic endothelial cells (BAE) were
routinely maintained in EGM2V medium (Lonza) in 24 well plates
in a 5% CO2 humidified atmosphere at 37uC as described by the
manufacturer. Cells were used between passages 9 and 20. Co-
culture with parasites was conducted in the parasite medium.
Trypanosome strains
Six Trypanosoma congolense strains of the Savannah type were used
in this study. IL1180 originated from the Serengeti in Tanzania
[16]. ILC-49 was originally isolated from a cow from the
Transmara, Kenya, and was passaged in rodents [17]. This strain
and its derivative, clone IL3000, were kindly provided by the
International Livestock Research Institute, Nairobi, Kenya.
STIB910 is a cloned derivative of STIB249 originally isolated in
1971 from a lion in Tanzania [16], and was kindly provided by R.
Brun (Basel, Switzerland). TREU1457 was derived from a stock
originally isolated in Nigeria (Zaria/67/LUMP/69) [18] kindly
provided by C.A. Ross. TRUM183:29-13 is a genetically modified
version of the TRUM183 strain, an uncloned serodeme, kindly
provided by J.E. Donelson [11].
Parasite culture
Details on culture media used are listed in Table 1. Procyclic
forms (PCF) were routinely maintained in TcPCF-3 medium. Cells
were maintained in log-phase culture at 27uCi n2 5c m
2 flasks by
changing the medium every 3 days.
Epimastigote adherent forms (EMF) appeared in this medium
after several weeks of culture by maintaining the culture in
stationary phase (change of half of the medium every 4 days). The
entire culture supernatant was replaced with fresh medium every
2–3 days, after the colonies of EMF were well established.
Alternatively, EMF could be cultivated in a few hours using a
starvation medium named TcEMF-1. Briefly, 5 ml of PCF culture
(<10
7 cells/ml) was collected by centrifugation (16006g, 10 min),
placed in the same volume of TcEMF-1 medium and incubated at
27uCi n2 5c m
2 flasks for 2 hours. Individual adherent EMF or
colonies were observed after only 1 hour. Heat-inactivated fetal
calf serum (10%, Adgenix) was added to the flask and this medium
(named TcEMF-2) was used to maintain the obtained EMF
culture as described above.
Metacyclic forms (MCF) developed in the EMF cultures after
few days up to few weeks depending on the strain. MCF could be
purified by DE52 anion-exchange column chromatography
(Whatman Plc., Brentford, U.K.) [19]. Furthermore, the number
of MCF produced per ml of EMF culture were quantified using a
haemocytometer.
For bloodstream forms (BSF) cultures, endothelial cells were
used as a feeder cell layer. BAE were seeded in 24-well plates.
After one day, the medium was removed, cells were washed with
PBS (phosphate-buffered saline: 137 mM NaCl, 10 mM Phos-
phate, 2.7 mM KCl, pH 7.4) and incubated in 1 ml of BSF
specific medium. BSF were cultured in 2 different media, the
TcBSF-3 was used during the adaptation phase from the infected
mouse blood or from metacyclic differentiation and the TcBSF-1
was used for well-established cultures. BSF were always main-
tained at 34uC in a humidified atmosphere containing 5% (vol/
vol) CO2.
Cultivation of parasites isolated from mouse blood
Parasites collected from infected mouse blood could be either
differentiated in PCF or cultivated as BSF. Cultures were initiated
Author Summary
Trypanosoma congolense is a parasite responsible for
severe disease of African livestock. Its life cycle is complex
and divided into two phases, one in the tsetse fly vector
and one in the bloodstream of the mammalian host.
Molecular tools for gene function analyses in parasitic
organisms are essential. Previous studies described the
possibility of completing the entire T. congolense life cycle
in vitro. However, the model showed major flaws including
the absence of stable long-term culture of the infectious
bloodstream forms, a laborious time-consuming period to
perform the cycle and a lack of genetic tools. We therefore
aimed to develop a standardized model convenient for
genetic engineering. We succeeded in producing long-
term cultures of all the developmental stages on long-
term, to define all the differentiation steps and to finally
complete the whole cycle in vitro. This improved model
offers the opportunity to conduct phenotype analyses of
genetically modified strains throughout the in vitro cycle
and also during experimental infections.
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minimum of 10
8 parasites/ml. 5 drops of tail blood were collected
in 1 ml of TcPCF-1 or TCPCF-2 media for differentiation in PCF
or in 1 ml of TcBSF-3 for BSF culture. A few derivatives of the
TcBSF-3 medium were also used during the adaptation medium
development phase by using horse, foal or lamb sera (Invitrogen)
instead of goat serum. Centrifugation (2006g, 1 min) was used to
remove the majority of red blood cells. Parasites present in the
supernatants were subsequently incubated in 24 well plates at
27uC for PCF, and at 34uC in a humidified atmosphere containing
5% (vol/vol) CO2 for BSF.
For PCF, half of the medium was replaced as soon as the well-
shaped parasite density in the upper part of the well reached the
middle log phase (<5.10
6 cells/ml). This process could take a few
days to a few weeks depending on the strain. Following this
adaptation phase, half of the medium was changed every 2 days.
Vectors
pLEW13, pLEW29 with a modified integration site (here
named pLEW29c) and p2T7
Ti/aTUB were kindly provided by
J.E. Donelson [11]. pLEW20 is a typical expression vector for T.
brucei [20], which allows inducible expression of proteins under the
control of a strong pol I promoter regulated by two tetracycline
operators. To facilitate the integration and the subsequent
expression of reporter proteins in T. congolense, the integration site,
the rRNA spacer region (1 to 121), was replaced by the bTUB
region (1 to 134) of the pLEW13 vector. A PCR fragment from the
pLEW13 was produced using specific primers containing ScaI and
NdeI restriction sites respectively, sub-cloned in pGEM-T vector
(Promega), and inserted in the pLEW20 ScaI-NdeI restricted
plasmid. This new vector, named pLEW20c, was used to produce
the enhanced green fluorescent protein (EGFP: optimized for
expression and fluorescence in mammalian cells) or the Renilla
luciferase (RLuc). PCR amplified fragments corresponding to
EGFP and RLuc were inserted in the HindIII-BamHI restriction
sites of the pLEW20c vector to produce pLEW20c-EGFP and
pLEW20c-RLuc.
Trypanosome transfection
Stably transfected strains were obtained with the Amaxa
nucleofection method. The Amaxa NucleofectorH system (Lonza,
Levallois-Perret, France) was used as described by the manufac-
turer. Briefly, a pellet of 10
7 parasites was resuspended in 100 mlo f
Basic Parasite NucleofectorH solution, mixed with 15 mg of NotI
linearized plasmid and subjected to nucleofection with a specific
program. Amaxa solutions and programs used are listed in Table 2.
Stably transfected trypanosomes were selected using BSF or PCF
media supplemented with bleomycin for pLEW20c and p2T7
Ti/
aTUB, G418 for pLEW29c and hygromycin for pLEW13.
Increasing concentrations of antibiotics were used for BSF
selection (from 0.5 mg/ml to 2 mg/ml Bleomycin; 0.25 mg/ml to
1.25 mg/ml Hygromycin and 0.1 mg/ml to 0.5 mg/ml G418),
while a fixed concentration was used for PCF (2 mg/ml Bleomycin,
2.5 mg/ml G418 and 6.25 mg/ml Hygromycin). During BSF
selection, half of the medium was changed every two days by
carefully removing it without disturbing the adherent parasites.
For PCF, the medium was not changed until the parasite density
reached at least 5.10
6 cells/ml. After the selection phase, single
clones were generated by limiting dilution, expanded and assessed
by either PCR on genomic DNA (using primers specific of the
vector amplifying the resistance gene) or luciferase activity
quantification or GFP fluorescence depending on the vector used.
Transgene induction was achieved by growing the cells in the
presence of 1 mg/ml of tetracycline.
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The Renilla Luciferase Assay System (Promega, Charbon-
nie `res-les-bains, France) was used to measure in vitro luciferase
activity as described by the manufacturer. Briefly, non-trans-
formed and pLEW20c-Rluc-transfected T. congolense clones were
grown to a total of 5.10
6 parasites/ml and centrifuged (15006g,
10 min). The pellet was washed with PBS, resuspended in 20 ml
lysis buffer and added to 100 mlo ft h er e a c t i o nm i x .Renilla
luciferase activity was monitored over 5 min every 10 sec after
substrate addition by using an Optima microplate reader (BMG
Labtech, Germany) and expressed as relative light units (RLU)
per mgp r o t e i n .
Immunofluorescence analyses
PCF were collected by centrifugation (16006g, 10 min) of
culture supernatants. Individual EMF were collected by brief
washing of the adherent cells with PBS and gentle scraping of the
colonies with a cell scraper followed by centrifugation (16006g,
10 min). MCF were purified from culture supernatants by DE52
anion-exchange column chromatography (Whatman Plc., Brent-
ford, U.K.) [19]. BSF were collected by extensive flushing of the
culture to remove adherent cells followed by centrifugation
(16006g, 10 min). To observe EMF colonies, glass coverslips
were placed in 24-well plates and incubated with EMF until
formation of colonies (the process can take a few days). To
analyzeBSF/BAE interactions, BAE cells were first incubatedfor
at least six hours on glass coverslips placed in 24-well plates to
allow them to adhere before addition of the BSF and co-culturing
for several hours. Cells were fixed with formaldehyde as
described [21]. Slides were then incubated with mouse anti-
paraflagellar rod (PFR) antibodies (anti-PFR2 L8C4 monoclonal
antibody diluted 1:100), kindly provided by K. Gull, (Oxford,
U.K.)) in PBS 0.1% (vol/vol) Triton X-100 0.1% (wt/vol), BSA
for 30 min, washed three times with PBS and incubated for
30 min with Alexa Fluor 488 goat anti-mouse IgG secondary
antibody (diluted 1:100) (Molecular probes). Finally, cells were
incubated for 5 min with 1 mg/ml 49,69-diamidino-2-phenylin-
dle (DAPI) and mounted in Vectashield (Vector Laboratories).
Cells were observed with a Zeiss UV microscope and images
were captured using a MicroMax-1300Y/HS camera (Prince-
ton Instruments) and Metaview software (Universal Imaging
Corporation).
Direct observations of parasites in culture were also conducted:
cells were observed with an Axiovert (Zeiss) UV microscope and
images were captured by an Axiocan camera (Zeiss) and
Axiovision 3.0 software (Zeiss).
Table 2. Amaxa nucleofection assays.
Strain
Amaxa
Solution Program number Vector
Positive assay/
total Transfectant analysis
PCR Fluo Activity
PCF
IL3000 T-cells X-001, X-006, U-033 pLEW13 0/3
Parasitic 1 U-033 pLEW13 0/1
Parasitic 2 X-001 pLEW13 1/1 X
X-001 pLEW20c-GFP 1/1 X
IL3000:13 Parasitic 2 X-001 pLEW29c 1/2 X
IL3000:13–29 Parasitic 2 X-001 pLEW20c-GFP 1/1 X
X-001 pLEW20c-Rluc 1/1 X
X-001 p2T7
Ti/aTUB 1/2 X
Treu183:13–29 Parasitic 2 X-001 pLEW20c-GFP 1/1 X
pLEW20c-Rluc 1/1 X
p2T7
Ti/aTUB 1/1 X
BSF
IL3000 T-cells X-001, X-006 pLEW13 0/2
Parasitic 1 U-033 pLEW13 1/1 X
Parasitic 2 U-033 pLEW13 1/1 X
U-033 pLEW20c-Rluc 0/1
IL3000:13 Parasitic 2 X-001, U-033 pLEW29c 0/7
STIB910 T-cells X-001, U-033 pLEW13 0/3
X-006 pLEW13 1/1 X
Parasitic 1 X-001, X-006 pLEW13 0/2
Parasitic 2 X-001 pLEW13 1/1 X
X-001 pLEW20c-Rluc 1/1 X
STIB910:13 Parasitic 2 X-001, U-033 pLEW29c 0/8
X-001 p2T7
Ti/aTUB 0/1
IL3000:13–29 Parasitic 2 X-001 pLEW20c-Rluc 1/1 X
Once selected, transfectants were analyzed by PCR on genomic DNA, observation of EGFP fluorescence, or Renilla luciferase activity measurement.
doi:10.1371/journal.pntd.0000618.t002
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Total protein preparations of trypanosomes were obtained by
lysis of live parasites with 2% (wt/v) SDS (10 ml per 10
6 parasites)
and heating at 100uC in the presence of a protease inhibitor cocktail
(complete Mini, EDTA-free; Roche Diagnostics, GmbH). 10 mlo f
this lysate was loaded per well and separated by SDS-PAGE (12%)
before transfer onto polyvinyl difluoride (PVDF) membranes
(Immobilon-P, Millipore) and processed for Western blotting as
described previously [22]. Monoclonal antibodies (mAb) #491 and
#3C6 were kindly provided by T. W. Pearson and B. Loveless
(Victoria, Canada). mAb #491 recognizes a carbohydrate epitope
present on the protease-resistant surface molecule of T. congolense
and on other surface molecules of T. congolense and T. simiae [12,23].
mAb #3C6 was made by B. Loveless against recombinant CESP
procured by N. Inoue (B. Loveless and T. W. Pearson, unpublished
data). Membranes were incubated for 2 hours with dilutions of
hybridome culture supernatant (1:10) or mouse anti-T. brucei tubulin
(1:2,000). Antigen-antibody interactions were revealed with the
Immobilon Western chemiluminescent horseradish peroxidase
substrate (Millipore).
Experimental infection of mice
Eight-week-old femaleBalb/cmicewerepurchasedfromCharles
River Laboratories (L’arbresle Cedex France), NOD/SCID
(NOD.Cg-Prkdescid Il2rgtm1 Wjl/Szj) were bred locally in specific
pathogen-free conditions and used for experiments from five to six
weeks of age. All animal studies adhered to protocols approved by
the University of Bordeaux 2 animal care and use committee and
the commission de genie genetique (Direction Generale de la
Recherche et de l’Innovation). Balb/c mice either treated or not
with the immunosuppressant cyclophosphamide (200 mg/kg,
Sigma-Aldrich) or NOG mice were inoculated by intraperitoneal
injection with variable amounts of infectious trypanosomes.
Inoculated parasites were: (i) purified MCF, (ii) a mix of EMF and
MCF from cell culture supernatants, (iii) BSF cultivated in vitro or
from infected mouse blood. Parasitaemia was subsequently
monitored daily by microscope observation. Blood samples were
collected three times a week by tail bleed in 100 ml capillary tubes
coated with Na-heparin. To determine the packed red blood cell
volume percentage (PCV), capillary haematocrit tubes were sealed,
centrifuged (15,000 rpm, 12 min) and analyzed with the haemato-
crit reader supplied by the manufacturer (Heraeus).
Results
Effect of medium composition on procyclic
differentiation and culture
T. congolense PCF adaptation to an axenic culture system directly
from infected mice blood was described previously [24]. However,
with described methods and media, for most of the isolates,
differentiation efficiency was low and required several months to
attain stable culture. Furthermore, some strains could not undergo
the adaptation process to axenic culture. Therefore, we aimed to
standardize a simple method for rapid initiation from infected
blood and subsequent stabilization of PCF in continuous culture.
Blood samples were collected from mice experimentally infected
with various strains (IL3000, ILC-49, IL1180, TREU1457,
TRUM183:13–29, STIB910). When the parasitaemia reached
the mid log phase (,5.10
6 cells/ml), a few drops of tail blood were
placed in 1 ml of media (TcPCF-1, TcPCF-2 or TcPCF-3; Table 1)
and inoculated in 24-wells plates at 27uC after discarding most of
the red blood cells by centrifugation. TcPCF media are derived
from the 109-c medium [24] with variation in serum nature and
percentage, and presence of cis-aconitate and citrate.
BSF were always transformed into PCF within 2 days but
degenerated cells (abnormal shape, giant or clustered cells), unable
to divide, appeared soon after and settled at the bottom of the well.
These abnormal cells constituted the major part of the culture
during the first 3–10 weeks before giving way to well-shaped
dividing PCF. This adaptation phase is the critical step. When the
culture reached at least 5.10
6 cells/ml, the medium was changed
with 1 ml of fresh medium. After a few days, the doubling time
reached its maximum (8–15 hours depending on the strain) and
the culture was transferred to 25 cm
2 flasks and standard
cultivation methods in TcPCF-3 medium were applied. The
presence of 3 mM of cis-aconitate and citrate shortened the
adaptation phase to at least 2 weeks, probably facilitating the
differentiation process as described for T. brucei [25,26]. Further-
more, this adaptation phase could only be conducted in TcPCF-2
(goat serum instead of fetal calf serum) for ILC-49 and
TRUM183:13–29. In contrast, all the other tested strains
preferred the TcPCF-1 medium. For the multiplication step, all
strains grew faster in TcPCF-1. The length of time required to
achieve a stabilized PCF culture in flask is reported in Table 3 for
all the strains tested. We observed that even with this improved
Table 3. In vitro cycle timing and virulence of various T. congolense strains.
Strain
Differenciation timing during
metacyclogenesis (weeks) Virulence of
Mice survival
(Days)
Maximum
parasitaemia
(108/ml)
Minimum PCV
(%)
Mouse.PCF PCF.EMF EMF.MCF MCF BSF
ILC49 4t o6 3t o6 1t o2 2 acute 3.960.3 1.860.2 44.761.5
IL3000 3 to 4 1 to 3 1 to 2 acute acute 14.161.2 10.260.1 28.062.6
IL1180 3 to 4 3 to 6 1 to 2 chronic chronic 48.764.6 5.460.3 25.363.0
TREU 1457 4 to 6 3 to 6 1 to 2 acute acute 12.161.6 5.260.2 30.262.8
STIB 910 6 to 8 3 to 6 1 to 2 acute acute 11.963.2 10.160.4 26.161.6
TRUM183:13–29 3t o4 3t o6 1t o2 2 acute 15.264.3 5.660.3 31.362.1
IL3000:13–29 3t o4 4t o8 1t o2 2 acute 13.262.6 5.460.1 28.661.4
Mice survival, Maximum parasitaemia and Minimum PCV were expressed as mean values calculated from experimental infections of at least 5 mice after infection with
10
7 BSF obtained after at least 5 passages in mice. Timings were the same whether TRUM183:13–29 and IL3000:13–29 were transfected with pLEW20c derivatives or not.
MCF were purified from in vitro cultured parasites by DE52 column chromatography, BSF were present in mouse blood after at least 5 passages.
doi:10.1371/journal.pntd.0000618.t003
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dependant.
Procyclic transfection and genetic tool design
Transgene expression and RNA interference (RNAi) in T.
congolense PCF have been reported previously [11,27]. Specifically,
the tetracycline inducible system first used in T. brucei (constitutive
expression of RNA polymerase and tetracycline repressor, [5]) has
been adapted for T. congolense by Inoue and colleagues in the
TRUM183 uncloned serodeme [11]. Nevertheless, classical
electroporation methods are not sufficient to ensure an acceptable
success rate of transfection in several other strains (our data). For
example, the most used and currently sequenced (Sanger Center)
IL3000 strain is awkward for genetic manipulation (upon our data:
less than 30% of electroporation assays lead to selection of stable
transfectants). Because transfection efficiency could be greatly
enhanced in the parasite T. brucei using the Amaxa nucleofection
method [28], we applied this technology to T. congolense.
To test this method on T. congolense PCF, we tried 3 different
nucleofection programs and 3 different Amaxa solutions recom-
mended by the manufacturer with different vectors as described in
material and methods: p2T7
Ti/aTUB as RNAi control experi-
ment, pLEW20c-EGFP and pLEW20c-Rluc allowing inducible
transgene expression of EGFP, Renilla luciferase, pLEW13 and
pLEW29c inserted successively in the IL3000 genome to devise a
tetracycline inducible system. The new cell-line was named
IL3000:13–29. Stable transfection achievement has been assessed
by PCR on genomic DNA and by GFP fluorescence or luciferase
activity measurement. Results are reported in Table 2. The best
results were obtained with the Parasitic 2 Amaxa solution and the
X-001 program: independently of the T. congolense strain used,
nearly 100% of the transfection assays led to selection of stable
transfectants. With the other programs, electroporation led to cell
death at much higher levels. The inducible operating system was
also valued as shown in Figure 1, 2 and Table 4. Despite the
absence of tetracycline, a basal expression level of GFP
fluorescence and luciferase activity was observed; this is probably
the result of a leakage of the tetracycline inducible system, which
has already been described previously [20,29]. Upon addition of
tetracycline, transgene expression was enhanced as indicated by
the rise in fluorescence intensity (Figure 1) and the 4-fold increase
of luciferase activity (Table 4). For the RNAi experiment, as
expected, the a-tubulin gene expression generated an altered cell
morphology called the FAT phenotype [30] (Figure 2). Without
tetracycline, this phenotype is absent, after tetracycline addition,
the entire population displayed the lethal FAT phenotype within
48 hours. The absence of apparent leakage in this experiment is
probably due to the natural enrichment of the culture with more
tightly repressed cells due to the lethality associated with the FAT
phenotype. This hypothesis is reinforced by prolonged selection
Figure 1. Inducible expression of EGFP through the T. congolense life cycle. Microscope images of the in vitro cultivated IL3000:13–29 strain
transfected with pLEW20c-EGFP vector in all the developmental stages. Non induced and tetracycline (1 mg/ml for 48 h) induced cells were fixed and
visualized in phase contrast and by EGFP fluorescence (images were recorded with the same exposure time). Scale bars=1 mm.
doi:10.1371/journal.pntd.0000618.g001
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Ti/aTUB transfectants and decrease of the doubling
time in the course of the selection process.
Metacyclogenesis of wild type and transgenic strains
Cultivation of all the life cycle stages from the tsetse vector has
been described previously [8,9]. However, using these protocols,
production of infective MCF from insect form cultures could take
few weeks to several months depending on individual strains of T.
congolense [13]. The differences lay in cytoadherence timing,
interval between attachment, infective MCF appearance and in
the number of MCF produced. In order to shorten the
metacyclogenesis process. We aimed to improve the differentiation
efficiency in terms of timing and standardization.
First, to asses timing differences among strains, we tried to
perform metacyclogenesis using the described methods with the
wild type strains IL3000, ILC-49, IL1180, TREU1457, STIB 910
and the genetically modified cell lines TRUM183:13–29 and
IL3000:13–29 transfected with either pLEW20c-Rluc, pLEW20c-
EGFP or p2T7
Ti/aTUB. PCF were inoculated with 5.10
6 cells/ml
in TcPCF-3 medium containing the optimal concentrations of
glutamine and proline (2 mM glutamine and 10 mM proline) for
metacyclogenesis as described by C. Ross [10]. These conditions
were verified to be optimal (data not shown). After inoculation,
half of the medium was changed every 2 days. To appreciate
metacyclogenesis development, we considered several criteria to
characterize the EMF and the MCF. (i) The first observed event
Figure 2. Inducible RNAi on tubulin genes through the T. congolense life cycle. Phase contrast microscope images of the in vitro cultivated
IL3000:13–29 strain transfected with p2T7
Ti/aTUB vector in all the developmental stages. Non induced and tetracycline (1 mg/ml for 24 h and 48 h)
induced cells are presented. PCF, EMF colonies, MCF (after DE52 purification) and BSF on BAE feeder cell layer were observed directly in the culture
medium. In the insets, PCF and MCF were fixed and stained with 4,6-diamino-2-phenylindole (DAPI) before observation in phase contrast. Scale
bars=10 mm.
doi:10.1371/journal.pntd.0000618.g002
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bottom of the flasks, grew and formed adherent bundles. (ii) Cell
shape, size and kinetoplast and its attached flagella localization in
relation to the nucleus change during metacyclogenesis process.
These main morphological features were examined microscopi-
cally. For kinetoplast positioning, cells were labeled with a flagellar
marker (anti-PFR antiserum) and stained with DAPI for
orientation. (iii) MCF emergence was highlighted by purification
on DE52 anion exchange chromatography. MCF infectivity assay
in mice is described bellow. (iv) Stage specific markers were
analyzed by western-blot, using two specific monoclonal antibod-
ies. According to the literature, mAb #491 recognizes carbohy-
drate epitope shared by different surface molecules (such as PRS,
GARP and CESP) differentially expressed during metacyclogen-
esis and mAb #3C6 binds to the EMF specific protein CESP
[12,23]. Results are presented in Figure 3 and Table S1. We
confirmed that metacyclogenesis was successful as we chiefly
observed the kinetoplast repositioning through the cycle (kineto-
plast is always anterior to the nucleus in the EMF contrary to
being on the posterior end in PCF and MCF) and MCF
appearance within 1–2 weeks after cytoadherence. Furthermore,
the expression pattern of stage specific markers is in agreement
with published data on in vitro differentiated EMF: CESP is
specifically induced in EMF stage and carbohydrate epitope
presence is strongly increased during the PCF to EMF
differentiation [12]. Nevertheless, we observed a large discrepancy
among wild type strains with, for example, a required period of 3
to 10 weeks to observe cytoadherence for wild type strains.
Moreover, differentiation was more difficult for genetically
modified parasites since MCF getting required several months.
For all the strains, the critical step seemed to be EMF
differentiation.
Subsequently, we focused on the method to optimize this step
by using the IL3000 strain. First, we attempted to influence the
Table 4. Luciferase activity in the T. congolense pLEW20c-Rluc transfected strains.
Strain Clone Tetra Luciferase Activity (RLU/mg of proteins) in the different parasitic stages
PCF EMF MCF BSFc BSFb
Treu 183:13–29 pLEW20_LucR C2 2 356632 294621 437633 370627 98622
+ 1233626 978624 978636 1061632
IL3000:13–29 pLEW20_LucR C6 2 235641 nd nd 300630 136629
+ 1045634 nd nd 1288619
B1 2 288610
+ 1300635
IL3000 pLEW20_LucR B2 2 1467632
Tetra: absence (2) or presence (+) of tetracycline (1 mg/ml) in the culture. BSFc: cultivated BSF, BSFb: BSF from infected mice blood. nd: not determined.
doi:10.1371/journal.pntd.0000618.t004
Figure 3. Morphological features and molecular markers analysis during metacyclogenesis. A, Wild-type individual IL 3000 cells were
labeled with monoclonal anti-PFR antibody during metacyclogenesis. For orientation the fixed cells were also stained with 4,6-diamino-2-
phenylindole (DAPI) and visualized in phase contrast. Scale bar=1 mm. B, Western blot analysis of stage specific markers during the
metacyclogenesis. 10
6 cells of IL3000 were loaded per well. Tubulin was used as a loading control. Molecular weights are indicated on the blots side.
iEMF: induced EMF in the absence of serum. Identical results were observed with the other T. congolense isolates and with transfected parasites.
doi:10.1371/journal.pntd.0000618.g003
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the culture. Unexpectedly, we observed a significant increase in
the rate of cytoadherence (few days instead of weeks) when a
density higher than 2.10
7 cells/ml was used, corresponding to the
stationary phase. All the strains were subjected to this treatment
and EMF differentiation followed by MCF differentiation was
noted (results are reported in Table 3). With this treatment, all the
strains were able to pass through metacyclogenesis and parasites fit
all the stage specific features described above, but variations in
EMF differentiation timing were observed. Conversely MCF
always appeared within 2 weeks. One of the features of stationary
phase is depletion of metabolites in the medium. Taking this into
consideration, we used a medium containing only base powder,
glutamine, proline and no serum, TcEMF-1. Surprisingly, in this
medium, individual cells and bundles of adherent IL3000 cells
appeared after 30 minutes and reached a maximum after 2 hours.
Prolonged exposure time in the absence of serum resulted in cell
death. Therefore, after 1–2 hours, we added 10% FCS in this
medium to produce TcEMF-2. Half of the medium was then
changed every two days and it was found that MCF always
appeared after 1–2 weeks. Adherent cells induced by serum
depletion (named iEMF for induced EMF) displayed the main
EMF criteria (cytoadherence, shape, kinetoplast positioning and
ability to differentiate in MCF) but exhibited differences in
molecular markers (Figure 3B). Indeed, no signal was observed
either with mAb #491 or #3C6, which implies that CESP is not
expressed and the carbohydrate epitope is absent.
This rapid method was tested on all the strains and worked even
for transgenic strains: iEMF always appeared within 1 hour and
MCF within 1–2 weeks. To confirm the potential use of the
process to conduct functional analysis through the life cycle, GFP
fluorescence, luciferase activity and FAT phenotype were
determined in transfected strains either induced or non induced
(Figure 1, 2 and Table 4). As expected, the results are similar to
those of PCF. This process provides the opportunity to test
phenotypes rapidly and efficiently throughout the parasite’s
developmental stages of the tsetse fly.
Impact of in vitro culture on infectivity and virulence
To assess infectivity and virulence of in vitro MCF, we injected
10
7 parasites into Balb-c mice and measured the level of
parasitaemia. The different strains were not equally infective for
mice (Table 3). IL3000, TREU1457 and STIB910 produced an
acute parasitaemia with a single peak, a high parasite load, a
strong anaemia and death within 2 weeks (Figure S1). IL1180
resulted in a chronic infection with a fluctuating blood
parasitaemia leading to a survival time greater than one month
(Figure S1). As for ILC-49 and transgenic cell lines, MCF were not
infective and consequently no parasites were observed in the
blood.
Previous parasitological studies associated T. brucei virulence
differences with the capacity of sub-cellular membrane fractions to
induce immunosuppression [31]. For this reason, we used
immunosuppressed mice (cyclophosphamide pretreated Balb-c)
and immunodeficient mice (NOD/SCID) in order to by-pass the
lack of infectivity and allow these strains to develop in the murine
host (Figure 4). MCF resulted in parasitaemia only in immuno-
deficient mice with a long prepatent period (at least 1 month). On
the other hand, once parasites appeared, we observed a high
parasite load, development of anaemia and death within two
weeks. Subsequently, 10
7 BSF containing blood was injected into
new Balb-c mice pretreated or not with cyclophosphamide or into
NOD/SCID mice. We obtained similar results as the parasitaemia
only developed in NOD/SCID mice albeit with a shorter
prepatent period (after 2 weeks). During the second passage,
BSF were observed not only in NOD/SCID mice but also in
immunosuppressed Balb-c mice. Following the third passage,
blood samples were infective in immunocompetent Balb-c mice.
For the fourth passage we observed the same infectivity and
virulence through passages resulting in the development of acute
parasitaemia with parameters comparable to those obtained with
blood BSF stocks never cultivated in vitro (field isolates directly
adapted to rodents) (Table 3).
To gain a better understanding of this phenomenon, we
examined the possibility of a requirement of a host adaptation step
for these non-infective MCF. Indeed, it has been described that
MCF of the same T. congolense clone produced by tsetse fed with
various host blood displayed virulence differences in mice and
required an adaptation period to develop in mice [32].
Furthermore some T. vivax field isolates have been adapted to
rodents using intraperitoneal inoculation of goat serum [33]. We
therefore, injected 500 ml of goat serum intraperitoneally in
immunosuppressed Balb-c mice one day before parasite infection
and every subsequent day until BSF were observed in the blood.
We observed parasites as soon as one week after MCF inoculation
and mice eventually developed an acute parasitaemia. This
protocol did not work with immunocompetent mice. The same
treatment was required for the first passage in mice. From the
second passage, goat serum injection was not essential and blood
samples were infective in immunocompetent Balb-c mice. These
data confirmed the existence in some strains of an adaptation
process to the murine host.
Setting-up long-term BSF cultures
We aimed to develop long-term cultures of T. congolense BSF in
order to conduct drug trials and genetic modifications. We
followed the described procedures to obtain BSF from infected
Figure 4. Infectivity of TRUM183:13–29 cell-line through mice passages. 10
7 in vitro differentiated MCF or a volume corresponding to 10
7
parasites of infected mice blood were injected in Balb-c, Balb-c pretreated with cyclophosphamide or NOD/SCID mice. Development of parasitaemia
was monitored by microscopic observation of mice blood every two days during 2 months. 2 means that no parasite could be observed during the
time period of observation, + means that parasitaemia developed during the time period of observation.
doi:10.1371/journal.pntd.0000618.g004
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soon began to degenerate and the culture collapsed after 3 to 10
days depending on the strain. We investigated the consequences of
varying media components such as serum and base powder. We
inoculated standard T. brucei BSF medium containing either
IMDM or MEM base powder and derived media containing 20%
of various sera (horse, foal, lamb, goat) as described earlier [34].
The results showed a preference for goat serum and MEM base
powder (data not shown). Supplementation of these media with
‘‘serum plus’’ increased cell density and attachment (TcBSF-1).
We also examined temperature effect by cultivating parasites
between 34uC and 37uC and observed higher longevity at 34uC.
But despite these improvements, the culture conditions were not
sufficient for long-term culture.
To go one step further with the culture system, we used
endothelial cells as feeder cell layer. Indeed, strong interactions
between vascular endothelium have been demonstrated in vivo
[35,36] and in vitro with BAE [37,38]. Addition of BAE greatly
improved the BSF condition as cells promptly interacted with BAE,
proliferated faster and could be cultivated for 3–4 weeks.
Nevertheless, this was not sufficient for the selection process of
stable transfectants since some major drawbacks remained: cultures
were very sensitive and preservation through freezing was not
possible. Eventually, we managed to settle BSF adaptation by
adding RBC lysate to the culture (TcBSF-2), and by using fresh goat
serum provided directly after sampling thus avoiding alteration
through preservation or treatment (chemical or irradiation) of the
commercial serum (TcBSF-3). Therefore, the adaptation process
had to be carried out in TcBSF-3, this phase lasted few weeks before
stabilization of the culture. All the strains tested could be cultivated
for at least a month but stabilization has been achieved only for
IL3000, IL3000:13–29 and STIB 910. When the culture is stable,
commercial goat serum can be used and RBC lysate and serum plus
were no longer essential to sustain growth.
To test our BSF culture system, we compared growth of T. brucei
and T. congolense in different media (Figure 5, Table S2). RBC
lysate and haemoglobin slightly improved growth rates for both
species and the absence of reducing agents affected T. brucei to a
greater extent than T. congolense. The absence of BAE in T.
congolense culture had a great impact on growth rate, and
furthermore, the culture was more sensitive as it was not possible
to inoculate with less than 2.10
5 cells/ml. It was also observed that
in the presence of BAE T. congolense reached the stationary phase
later and supported a higher cell density than T. brucei (2.10
7 cells/
ml vs. 4.10
6 cells/ml).
In addition, we subjected T. congolense MCF to differentiation
with this adaptation system in order to directly obtain BSF in vitro
avoiding the murine step. We obtained similar results: all the
strains differentiated in BSF and were cultivated for one month
and we completely stabilized IL3000, IL3000:13–29 and STIB910
for long-term culture. Infectivity and virulence of in vitro cultured
BSF were tested by inoculating mice with parasites cultured for
several months. Identical results were obtained as for MCF
(Table 3). To complete the in vitro cycle, the cultivated BSF were
subjected to PCF differentiation as described earlier. All the strains
tested passed through this step and gave rise to a stable PCF
culture.
Finally, we cultivated transfectant strains and managed to
observe the corresponding phenotype: GFP fluorescence, lucifer-
ase activity and FAT phenotype (Figure1, 2 and Table 4). This
experiment proved unambiguously the ability to fulfill phenotype
analysis of genetically modified cell lines during the complete life
cycle of T. congolense.
Transfection experiments on T. congolense bloodstream
forms
In the same way as PCF, we used the Amaxa nucleofection
technology to transfect BSF. It turned out that BSF transfection
was very difficult. Results are summarized in Table 2. We tried to
construct the inducible system based on the tetracycline repressor
directly in BSF and managed to achieve the first step, which was
the integration of the pLEW13 vector into the genome. However,
we failed to insert the second vector, pLEW29c, despite numerous
endeavors. We then attempted to perform a constitutive RNAi
Figure 5. Comparison of T. brucei and T. congolense in vitro growth. A, T. brucei 427 BSF have been inoculated at 5.10
4 cell/ml in TcBSF-1
(Table 1) medium at 37uC in a humidified atmosphere containing 5% (vol/vol) CO2. B, T. congolense STIB910 BSF have been inoculated at 5.10
4 in
presence of BAE (black curves) or at 2.10
5 cell/ml in absence of BAE (grey curves) in TcBSF-2 (Table 1) medium at 34uC in a humidified atmosphere
containing 5% (vol/vol) CO2. Parasites were cultured in their specific medium for five days (— — X) or in medium supplemented with red blood cell lysate
(resuspension of red blood cells vol/vol in cold water and 100 fold diluted in medium) (— — N), or with hemoglobin (100 mg/ml) (— *
), or in absence of
reducing agents (Bathocuproin, 2-mercaptoethanol and cystein were removed) (— — &). Cells were counted every 24 h.
doi:10.1371/journal.pntd.0000618.g005
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results with the pLEW20-Rluc vector and highlighted luciferase
activity (Table 4). We also achieved inducible expression of
luciferase by directly transfecting the IL3000:13–29 cell line
produced from the in vitro cycle. Direct transfection of T. congolense
BSF is therefore possible but remains arduous as it took several
weeks and the success rate was low.
Discussion
The development of a continuous culture system represents a
major breakthrough in T. congolense research. Indeed, parasite
biology studies imply understanding of its complex life cycle
including differentiation, environment adaptation, signaling, viru-
lence and pathogenesis, which become accessible once powerful
genetic tools such as RNAi are exploitable throughout the life cycle.
For the first time, we have conducted a systematic study, which
allowed us to define the best in vitro culture conditions for each stage
in terms of differentiation efficiency followed by long-term in vitro
culture design. In this way, we succeeded in reproducing the
complete in vitro life cycle allowing the study of genetically modified
cell-line phenotypes throughout the cycle (Figure 6).
Firstly, we designed a new enriched adaptation medium which
enabled the isolation of BSF directly from the blood of infected
Figure 6. In vitro culture system and genetic tools for T. congolense.A ,The different developmental stages cultured in vitro are represented as
individual cells for PCF and MCF as adherent cells forming colonies for EMF and on BAE layer for BSF. Scale bar=1 mm for PCF, MCF, BSF in infected
mouse blood and the lower photo of BSF on BAE layer. PCF, EMF and BSF are dividing cells as represented by the rounded arrow. BSF differentiation
can be achieved either by infection of mice and culture from blood or directly in vitro on BAE layer. B, Scheme of transgenic cell-line analysis through
the cycle starting from PCF (top) or BSF (bottom) transfection. Linearized vectors used in transfection assays are represented by a line and two boxes,
the black one represents the selection marker and the grey one represents the transgene (Tg).
doi:10.1371/journal.pntd.0000618.g006
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amenable to in vitro drug trials, preservation through freezing and
transfection assays. However, transfection of BSF remains a
difficult task as we were unable to perform direct RNAi
experiments but did succeed in overexpressing the luciferase
reporter gene. Secondly, we improved the efficiency of PCF
transfections and set up a tetracycline inducible system for the T.
congolense reference strain (IL3000, the strain used by the Sanger
Center for the genome sequencing project). We validated this
system by the inducible expression of reporter genes (GFP and
Luciferase) and an inducible RNAi experiment targeting the
essential tubulin gene as a control. Thirdly, we standardized
metacyclogenesis techniques, not only on wild type isolates, but
also on genetically modified parasites (either for transgene
expression or RNAi) and the time needed to achieve the
differentiation has been dramatically shortened to ,10 days
instead of months. Finally, BSF differentiation could either be
achieved by infecting mice or directly in vitro. Then, PCF
transfection followed by metacyclogenesis became an efficient,
rapid and reliable way to study gene function in all the
developmental stages as well as during the differentiation steps.
For the first time, powerful tools such as reverse genetics (gene
expression inactivation and characterization of resulting pheno-
types), becomes now available for this devastating parasite.
Adaptation of trypanosomatids to rodents for experimental
infections was essential to analyze the host-pathogen interaction
[39]. Specifically the use of inbred mouse models have proven to
be a valuable tool in pathology research [40]. Distinctness in
mouse susceptibility to trypanosomiasis among the mouse strains
is always observed. For example, for T. congolense and other
trypanosome species, BALB/c mice (compared to C57Bl/6) are
the most susceptible [41–43]. Discrepancy in virulence among
T. congolense isolates has also been reported in ruminant livestock
as well as in laboratory animals [44,45]. To go one step further
in the understanding of virulence mechanisms, it is essential to
analyze the phenotype of genetically modified parasites during
experimental infection. This is the reason why we assessed the
impact of long-term in vitro culture and of minor genome
modification on parasite infectivity and virulence. Results
showed that BALB/c mice are less susceptible to transfected
cell-lines as well as to 1 of 5 tested wild type savannah strains
after a complete in vitro life cycle. This deficiency in infectivity
can be overcome by using immunodeficient animals or goat
serum injected immunosupresssed mice. Furthermore, infectiv-
ity levels return to normal after few passages in the murine host.
T h es u r v i v a lt i m eo fi n f e c t e dm i c ei sa l w a y sc o r r e l a t e dw i t ht h e
parasitaemia peak arising and since the parasites developed, we
concluded that disease parameters like anemia are not
influenced by in vitro passage. These data indicate that while in
some cases the ability of the parasite to multiply and be
maintained in the host is lowered, parasite virulence is not
affected. We propose that infectivity decrease relies on a host
adaptation step. Development of parasitaemia in the mamma-
lian host implies for the parasite to fit the new environment in
terms of energy supplying and trypanocides conditions. Impair-
ment of the immune system could allow a time period sufficient
for the parasite to adapt to its new physiological state. Goat
serum injections might provide the parasite with essential factors
like nutriments and create a microenvironment promoting the
emergence of host adapted parasites that are able to develop in
mice blood. Such phenomenon has been suggested for T. vivax
adaptation to laboratory rodents using multiple passages in
irradiated rats and intraperitoneal injection of goat serum
[33].
This idea is in harmony with the requirement of goat serum
supplemented medium for T. congolense BSF in vitro culture.
Composition of this serum must suit the specific needs for parasite
growth. The concentrations of vitamins and related metabolites
vary from one sera to another. Goat serum is one of the most
commonly used to enhance cell multiplication [46,47]. The
greatest efficiency of fresh goat serum (not treated) reinforced the
hypothesis that the presence of labile components is required for
the parasite well-being. One can also notice that the 3 strains
impaired for infectivity (ILC-49, TRUM183:13–29 and
IL3000:13–29) are those which need goat serum to promote their
in vitro differentiation in PCF. These findings illustrated that even
for closely related strains (all are of the Savannah genetic group),
subtle differences in physiological requirements might exist.
Another important factor to promote BSF in vitro growth is the
presence of the erythrocyte lysate, which became dispensable after
some time. Haemoglobin is a component of red blood cells and we
showed that its presence in culture medium enhances the growth
rate of the parasite cultures. The first culture media described for
Trypanosoma spp. were always supplemented with blood lysate, then
replaced by hemin [48]. However, neither haemoglobin nor
hemin, are sufficient to ensure BSF adaptation from infected mice
blood (data not shown). Hemin is also essential for trypanosoma-
tids PCF differentiation and growth [24,49]. The parasite’s
inability to synthesize heme explains this requirement, since heme
containing proteins like cytochrome c [50], are essential for
parasite viability. However, erythrocyte lysate might provide the
parasite with other unknown components, which are essential
during the adaptation phase.
Generally, T. congolense culture has to mimic the host
environment. Thus, a high amino acid concentration in insect
forms media reflects the high proline content in tsetse hemolymph
subsequently used for energy metabolism of the parasite. An even
more striking similarity is the use of BAE layer to cultivate BSF.
Indeed, in infected animals, T. congolense BSF are found adhering
to erythrocytes and to endothelial cells of the microvasculature by
their flagellum [35,36,51]. This requirement is no longer essential
after an adaptation phase. Finally, production of infective MCF
requires strong adherence of EMF mimicking the bundles formed
in the fly proboscis. However, parasite journey in fly midgut then
in proboscis is complex and can’t be fully reproduced in vitro.
Especially coat antigens expression is refined and follows a defined
kinetic in the different insect stages. For example, one of the major
coat protein, GARP, is weakly expressed in early PCF, present in
the midgut then downregulated before being strongly expressed in
EMF isolated from proboscis [23]. In culture, this marker is
expressed in both stages PCF and EMF, reflecting an artefactual
absence of regulation during in vitro EMF differentiation [23].
Furthermore, Butikofer et al. [23] did not find reactivity with mAb
#491 on EMF from tsetse, although Sakurai et al. [12] did find
increased reactivity with EMF compared to PCF within in vitro
culture. Similarly, the iEMF phenotype (absence of CESP
expression and of the carbohydrate marker) may represent
another illustration of the importance of the environmental factors
on differentiation. Indeed, the difference observed in surface
markers may result from the absence of serum at the time of
differentiation or from the stress induced by the sudden
environment change. Nevertheless, despite the absence of those
markers iEMF are able to differentiate into infective MCF
suggesting that those surface markers expression is not essential
for in vitro EMF differentiation but must be involved in the in vivo
process where parasites have to attach themselves to the wall of the
labrum in the food canal to transform into EMF. The iEMF stage
could also represent a transitory stage in the insect. Furthermore
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adhesion implying that this protein is not essential for cytoadher-
ence and that other proteins might be involved. Successful culture
and differentiation of iEMF and EMF combined with targeted
gene deletion through RNAi represent powerful tools to
understand the elaborated mechanism of the metacyclogenesis
process encountered in the insect.
Parasites display a great ability to adapt but the required time
period for this adaptation is the limiting step in the initiation of
stable culture of the different developmental stages as well as for
experimental infections. We succeeded to go through this limiting
step to secure cultures of all the T. congolense developmental stages.
Standardization of media and methods using various strains, more
or less demanding, allowed the design of the complete in vitro
lifecycle of all the tested strains. Definition of these optimal
conditions also greatly improved the success rate of PCF
nucleofection, that should be very useful for routine genetics
based analysis.
To conclude, the ability to dominate the in vitro metacyclogen-
esis in combination with the transgenic PCF technique provides an
essential tool to investigate the functional role of T. congolense genes
throughout the cycle as well as in vivo during experimental
infections in mice.
Supporting Information
Figure S1 Acute and chronic infection in mice. 5 Balb-c mice
were infected with 104 parasites of IL3000 or IL1180 T. congolense
strains. Parasitaemia and PCV were measured and expressed as
mean values.
Found at: doi:10.1371/journal.pntd.0000618.s001 (0.29 MB TIF)
Table S1 Metacyclogenesis timing of various T. congolense strains.
Cytoadherence timing indicates the time required to observe an
increasing number of adherent cells at the bottom of the flask.
MCF number (mean of two experiments) was determined by
counting parasites after a DE52 chromatography, the experiment
was done on 10 ml culture in Tco-PCF3.
Found at: doi:10.1371/journal.pntd.0000618.s002 (0.20 MB TIF)
Table S2 T. brucei and T. congolense growth rates in different
media. Presence (+) or absence (2) of BAE feeder cell layer.
Normal, corresponds to routinely used medium for each species in
vitro culture. RBC, medium was supplemented with red blood cell
lysate as previously described. HB, medium was supplemented
with haemoglobin (100 mg/ml). red, reducing agents of the
medium (2-mercaptoethanol, bathocuproin and cystein) were
removed.
Found at: doi:10.1371/journal.pntd.0000618.s003 (0.09 MB TIF)
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